Based on these studies, the use of α7nAChR compounds in the treatment of cognitive impairment and AD looks promising, but caution should be exercised regarding the use of drugs which result in overt α7nAChR potentiation. The gene discussed is CHRNA7; the disease is Cognitive impairment.